Will Encidipine be included in medical insurance in 2024?
Regarding the question of whether Enasidenib (Enasidenib) will be included in the medical insurance in 2024, according to publicly released information, Ensidipine is currently not included in my country’s medical insurance catalog.
According to relevant information from the National Medical Insurance Administration, ensidipine (Enasidenib) has not been included in my country's medical insurance drug catalog in 2024. This means that in 2024, patients who use this drug may not be able to enjoy medical insurance reimbursement.

my country's medical insurance catalog will be adjusted and updated regularly to include more effective therapeutic drugs and eliminate some drugs with uncertain efficacy or easy abuse. However, the results of each adjustment need to be released through official channels to be confirmed. As of now, there is no official news that ensidipine has been included in the medical insurance catalog.
The adjustment of the medical insurance catalog is affected by many factors, including the efficacy, safety, economy and patient needs of drugs. For targeted therapeutic drugs such as ensidipine, their efficacy and safety have been widely recognized, but there may still be some controversy in terms of economics. In addition, the adjustment of the medical insurance catalog also needs to take into account the affordability of the medical insurance fund and the overall interests of patients.
Although ensidipine is not currently included in the medical insurance catalog, with the continuous improvement of medical insurance policies and the continuous advancement of medical technology, ensidipine may be included in the scope of medical insurance in the future. For patients who need to use ensidipine, they can pay attention to the latest developments in medical insurance policies and consult professional doctors for more treatment suggestions.
In summary, according to publicly released information, encidipine has not been included in my country's medical insurance directory in2024. However, whether it will be included in medical insurance in the future depends on the latest developments in medical insurance policies.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)